By Ben Glickman GSK has received approval from the Food and Drug Administration for its treatment for myelofibrosis. The British pharmaceutical company said Friday...
Almost a year ago I published an article analyzing briefly Costco (NASDAQ:COST) and my rushed conclusion was that investors should sell and find better...
Disclaimer: The text below is an advertorial article that is not part of Cryptonews.com editorial content. Cryptocurrency markets are known for their rapid fluctuations, and in...